Abiomed Inc (ABMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 12-2008 | 09-2008 | 06-2008 | 03-2008 | 12-2007 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -23,143 | -15,444 | -9,114 | -40,930 | -25,958 |
| Depreciation Amortization | 3,691 | 2,570 | 1,414 | 6,124 | 3,836 |
| Income taxes - deferred | 529 | 337 | 145 | 527 | 457 |
| Accounts receivable | -701 | -1,056 | 138 | -2,797 | -569 |
| Accounts payable and accrued liabilities | -4,369 | -2,640 | -1,846 | 3,237 | 1,654 |
| Other Working Capital | -8,586 | -9,306 | -6,613 | -8,025 | -5,616 |
| Other Operating Activity | 14,696 | 10,184 | 3,971 | 12,990 | 4,878 |
| Operating Cash Flow | $-17,883 | $-15,355 | $-11,905 | $-28,874 | $-21,318 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -25,943 | -26,956 | 9,653 | -31,936 | -39,544 |
| PPE Investments | -2,602 | -1,410 | -644 | -3,760 | -2,984 |
| Purchase Sale Intangibles | N/A | N/A | N/A | -69 | -58 |
| Other Investing Activity | 313 | 0 | 0 | -5,209 | -1,198 |
| Investing Cash Flow | $-28,232 | $-28,366 | $9,009 | $-40,905 | $-43,726 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 46,755 | 45,651 | 2,436 | 3,938 | 2,742 |
| Common Stock Repurchased | -711 | -658 | N/A | -1,868 | -1,868 |
| Financing Cash Flow | $46,044 | $44,993 | $2,436 | $2,070 | $874 |
| Exchange Rate Effect | 763 | -398 | 45 | 105 | 100 |
| Beginning Cash Position | 2,042 | 2,042 | 2,042 | 69,646 | 69,646 |
| End Cash Position | 2,734 | 2,916 | 1,627 | 2,042 | 5,576 |
| Net Cash Flow | $692 | $874 | $-415 | $-67,604 | $-64,070 |
| Free Cash Flow | |||||
| Operating Cash Flow | -17,883 | -15,355 | -11,905 | -28,874 | -21,318 |
| Capital Expenditure | -2,602 | -1,410 | -644 | -3,760 | -2,984 |
| Free Cash Flow | -20,485 | -16,765 | -12,549 | -32,634 | -24,302 |